World Health Organizaion (WHO), “Global statics and WHO HIV statics,” WHO, 2018.
 World Health Organization(WHO), “Global health observatory (GHO) data,” 2018. http://www.who.intghochild_healthmortalityneonatal_texten.
 United Nations Program on AIDS (UNAIDS) and UNAIDS, “Press release/ right to health report,” Cape town/Geneva, 2017.
 FHAPCO, “HIV prevention in ethiopia national road map 2018-2020.” FHAPCO, Ethiopia, 2018.
 United Nation Program on AIDS (UNAIDS), “HIV countries report/ Ethiopia (www.unaids.org/en/regionscountries/countries/ethiopia),” 2019.
 S. Croxford, A. Kitching, and S. Desai, “Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: Analysis of a national observational cohort,” Lancet Public Heal., 2017.
 T. Yohannis, S. Moges, and T. Laelago, “Survival Analysis of Adult Human Immune Virus Infected Patients under Antiretroviral Treatment at Wachemo University Nigist Ellen Mohammed Memorial Hospital, Southern Ethiopia,” Int. J. Intern. Med. Geriatr., pp. 21–32, 2019.
 K. Kebebew and E. Wencheko, “Survival analysis of HIV-infected patients under antiretroviral treatment at the Armed Forces General Teaching Hospital, Addis Ababa, Ethiopia,” Ethiop. J. Heal. Dev., vol. 26, no. 3, 2012.
 K. Tadesse, F. Haile, and N. Hiruy, “Predictors of Mortality among Patients Enrolled on Antiretroviral Therapy in Aksum Hospital , Northern Ethiopia : A Retrospective Cohort Study,” vol. 9, no. 1, 2014, doi: 10.1371/journal.pone.0087392.
 S. Hailemariam, “Determinants of Survival in HIV Patients: A Retrospective Study of Dilla University Hospital HIV Cohort,” Int. J. Virol. AIDS, vol. 3, 2016, doi: 10.23937/2469-567X/1510023.
 M. Tadege, “Time to death predictors of HIV / AIDS infected patients on antiretroviral therapy in Ethiopia,” BMC Res. Notes, pp. 1–6, 2018, doi: 10.1186/s13104-018-3863-y.
 D. Fekade et al., “Predictors of Survival among Adult Ethiopian Patients in the National ART Program at Seven University Teaching Hospitals: A Prospective Cohort Study,” Ethiop J Heal. Sci, vol. 27, no. Suppl 1, pp. 63–71, 2017, doi: 10.4314/ejhs.v27i1.7s.
 T. Digaffe, B. Seyoum, and L. Oljirra, “Journal of Tropical Diseases Survival and Predictors of Mortality among Adults on Antiretroviral Therapy in Selected Public Hospitals in Harar , Eastern Ethiopia,” vol. 2, no. 5, 2014, doi: 10.4172/2329-891X.1000148.
 S. Mengesha, B. Belayihun, and A. Kumie, “Predictors of Survival in HIV-Infected Patient after Initiation of HAART in Zewditu Memorial Hospital , Addis Ababa , Ethiopia,” vol. 2014, 2014, doi: 10.1155/2014/250913.
 M. T. Hambisa, A. Ali, and Y. Dessie, “Determinants of Mortality among HIV Positives after Initiating Antiretroviral Therapy in Western Ethiopia : A Hospital-Based Retrospective Cohort Study,” vol. 2013, 2013.
 J. Rubaihayo et al., “Trends and Predictors of Mortality Among HIV Positive Patients in the Era of Highly Active Antiretroviral Therapy in Uganda,” Infect Dis Rep, vol. 7, no. 3, p. 5967, 2015, doi: 10.4081/idr.2015.5967.
 B. Damtew, B. Mengistie, and T. Alemayehu, “Survival and determinants of mortality in adult HIV/Aids patients initiating antiretroviral therapy in Somali Region, Eastern Ethiopia,” Pan Afr Med J, vol. 22, p. 138, 2015, doi: 10.11604/pamj.2015.22.138.4352.
 K. Tesfamariam, N. Baraki, and H. Kedir, “Pre ‑ ART nutritional status and its association with mortality in adult patients enrolled on ART at Fiche Hospital in North Shoa , Oromia region , Ethiopia : a retrospective cohort study,” BMC Res. Notes, pp. 1–9, 2016, doi: 10.1186/s13104-016-2313-y.
 M. W. Demissie, “Statistical modeling for survival HIV/ADIS patients treated with highly active anti retro-viral treatment(HAART) :A case study at dilchora hospital. diredawa, Ethiopia ,” Jouranal biometrics Biostat., vol. 9, no. 5, p. 416, 2018.
 E. Tachbele and G. Ameni, “Survival and predictors of mortality among human immunodeficiency virus patients on anti-retroviral treatment at Jinka Hospital , South Omo , Ethiopia : a six years retrospective cohort study,” pp. 1–10, 2016.
 H. N. Luma et al., “Mortality in Hospitalised HIV / AIDS Patients in a Tertiary Centre in Sub-Saharan Africa : Trends Between 2007 and 2015 , Causes and Associated Factors,” pp. 162–173, 2018, doi: 10.2174/1874613601812010162.
 G. Zhang et al., “Outcomes and factors associated with survival of patients with HIV/AIDS initiating antiretroviral treatment in Liangshan Prefecture, southwest of China: A retrospective cohort study from 2005 to 2013,” Medicine (Baltimore)., vol. 95, no. 27, pp. e3969–e3969, 2016, doi: 10.1097/MD.0000000000003969.
 P. K. Ndombo et al., “A cohort analysis of neonatal hospital mortality rate and predictors of neonatal mortality in a sub-urban hospital of Cameroon,” Ital. J. Pediatr., vol. 43, no. 1, pp. 1–8, 2017, doi: 10.1186/s13052-017-0369-5.
 World Health Organizaion (WHO), “Antiretroviral therapy for HIV infection in adults and adolescents,” 2014.
 Biadgilign S, R. AA, and Digaffe T, “Predictors of mortality among HIV infected patients taking antiretroviral treatment in Ethiopia: a retrospec- tive cohort study.,” AIDS Res Ther., vol. 9, no. 1, p. 15, 2012.
 Tegiste A and Eshetu W, “Survival analysis of patients under chronic HIV-care and antiretroviral treatment at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.,” Ethiop. J. Heal. Dev. J Heal. Dev., vol. 26, no. 1, pp. 22–9, 2012.
 Federal Minster of Health (FMOH), “National consolidated guidelines for comprehensive HIV prevention, care and treatment,” 2018.